CAPD peritonitis caused by Alcaligenes xylosoxidans in a diabetic cirrhosis patient

Shang-Feng Tsai Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China

Kuo-Hsiung Shu Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China; School of Medicine, Chung-Shan Medical University, Taichung, Taiwan, Republic of ChinaCorrespondence[email protected]

REFERENCES

Ledger SG, Cordy P. Successful treatment of Alcaligenes xylosoxidans in automated peritoneal dialysis-related peritonitis. Perit Dial Int. 2007;27:596–598.
PubMed Web of Science ®Google Scholar
El-Shahawy MA, Kim D, Gadallah MF. Peritoneal dialysis-associated peritonitis caused by Alcaligenes xylosoxidans. Am J Nephrol. 1998;18:452–455.
PubMed Web of Science ®Google Scholar
Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980;11:141–145.
PubMed Web of Science ®Google Scholar
Tang S, Cheng CC, Tse KC, CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans. Am J Nephrol. 2001;21:502–506.
PubMed Web of Science ®Google Scholar
Selgas R, Bajo MA, Del Peso G, Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: Practical aspects and review of the literature. Perit Dial Int. 2008;28:118–122.
PubMed Web of Science ®Google Scholar
Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998;28:1187–1190.
PubMed Web of Science ®Google Scholar
Melgosa M, Espinazo O, Alonso A, Garcia Perea A, Navarro M. Dialysis-associated Alcaligenes xylosoxidans peritonitis: A pediatric case. Perit Dial Int. 2004;24:72–75.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

CAPD peritonitis caused by Alcaligenes xylosoxidans in a diabetic cirrhosis patient

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

CAPD peritonitis caused by Alcaligenes xylosoxidans in a diabetic cirrhosis patient

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date